Article
Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphoma
2022-10-11
Abstract excerpt
<h4>Purpose: </h4> An effective salvage regimen for the reinduction of remission is lacking for refractory or recurrent primary central nervous system lymphoma (r/r PCNSL). This study aimed to evaluate the efficacy and safety of high-dose cytarabine plus temozolomide in treating r/r PCNSL and to explore the associated prognostic factors. Methods A single-center retrospective cohort study was conducted to assess...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a17e357-c63d-5bd8-9541-9f08ed696a20
- DOI
- 10.21203/rs.3.rs-2135092/v1
